A human collagenase inhibitor (CI) of Mr 28,500 has been extensively characterized in skin fibroblasts and identified in a variety of connective tissues. Because human alveolar macrophages synthesize and secrete both a collagenase and CI that are immunologically and functionally identical to their counterparts in fibroblasts, we studied the production of such proteins by an immature human cell line Collagenases catalyze the initial and rate-limiting step of collagen degradation and thus occupy a pivotal position in both normal connective tissue turnover and in the tissue destruction that accompanies certain pathologic processes (1-5). Such enzymes have been isolated from a number of mammalian connective tissue cells (6-11) and inflammatory cells (12-15), including macrophages.
Collagenases catalyze the initial and rate-limiting step of collagen degradation and thus occupy a pivotal position in both normal connective tissue turnover and in the tissue destruction that accompanies certain pathologic processes (1) (2) (3) (4) (5) . Such enzymes have been isolated from a number of mammalian connective tissue cells (6) (7) (8) (9) (10) (11) and inflammatory cells (12) (13) (14) (15) , including macrophages.
It currently appears that collagenase-mediated connective tissue turnover is in reality a complex process that involves modulation of collagenolysis by specific CIs (16) (17) (18) (19) . It has recently shown that human alveolar macrophages may remodel collagen by this mechanism as the cells produce both a collagenase and collagenase inhibitor (CI) that are immunologically and functionally identical to the collagenase and CI elaborated by human fibroblasts (15) . Specifically, the CI is a glycoprotein of Mr 28,500 that blocks enzymatic activity with a high affinity and a 1:1 stoichiometry.
Since human alveolar macrophages elaborate proteins that can directly affect collagen degradation, the present studies were undertaken to examine the regulation of such molecules in cellular differentiation. To accomplish this, the human promyelocytic leukemia cell line, HL60, was employed. This cell line responds to chemical inducers by differentiating along a monocytic lineage [by 4p-phorbol 12 (20, 21) ]. We report here that untreated HL60 cells failed to synthesize or release either collagenase or CI; when induced to differentiate along monocytic or granulocytic pathways, however, they produced CI. Furthermore, monocytic differentiation was accompanied by elaboration of quantities of CI 3-to 5-fold greater than were produced by human alveolar macrophages. In contrast to alveolar macrophages, HL60s did not secrete collagenase under any tested condition.
MATERIALS AND METHODS Cells. HL60 cells, a human promyelocytic leukemia cell line (20) were obtained from E. Huberman (Argonne National Laboratories). The cells were grown in Iscove's modified Dulbecco's medium containing transferrin at 5 mg/ml, bovine serum albumin at 5 mg/ml, and 2 mM glutamine and were maintained in humidified 95% air/5% CO2 at 37°C.
Cell Treatment. The HL60 cells were plated in flat-bottomed wells (16-mm diameter) at 5 x 105 cells per well per ml of culture medium. When specified, the cells were treated with PMA (Sigma), retinoic acid (Sigma), Me2SO (Sigma), or vitamin D3 metabolites (courtesy of Milan Uskokovic, Hoffmann-La Roche). At the indicated times, the conditioned medium was removed and adjusted to 0.05 M Tris HCl/0.01 M CaC12, pH 7.5, or dialyzed overnight against 5 mM Tris HCl/1 mM CaCl2, pH 7.5, then lyophilized and suspended in water to achieve a 10-fold concentration. For the biochemical characterization studies, cells were plated in large tissue culture dishes (150 mm) and then exposed to the various inducing agents.
Flow Cytometry. HL60 cells were treated with different vitamin D3 metabolites (see Fig. 3 ). Induction of monocytic differentiation was assessed by monitoring for the appearance of 63D3 (a specific human monocyte surface marker) with an EPICS V flow cytometer (Coulter) as described (22) . Analysis of antibody binding (percent positive cells) was performed on a TERAK LSI/1123 microcomputer using the program IMMUNO written by C. Bruce Bagwell (Coulter).
Proc. NatL Acad Scd USA 82 (1985) 5381 Chromatography. Conventional chromatography was carried out at 40C, with column effluents monitored at 280 nm. High pressure liquid chromatography was carried out at ambient temperatures (160-20'C) using a Waters Associates system. Conditioned medium (200 ml) from PMA-treated HL60 cells was dialyzed against 0.05 M Tris HCl, pH 7.5, and applied to a 2.5 x 10 cm column of phosphocellulose (P-li, Whatman). The column was washed with 0.05 M Tris-HCI, pH 7.5, at a flow rate of 25 ml/hr for 24 hr and the bound protein was eluted with 0.05 M TrisHCl, pH 7.5/0.5 M (NH4)2SO4. The fall-through fractions contained >90% of the total protein applied to the column while the eluted material contained >90% ofthe CI as measured by an ELISA (18, 19) . An aliquot of the eluted protein was then subjected to HPLC using a Bio-Rad TSK-250 (7.5 x 300 mm) gel filtration column. The column was equilibrated with 0.05 M Tris-HCl, pH 7.5/0.10 M Na2SO4 and eluted at 0.8 ml/min. Half-minute fractions were collected and the absorbance at 229 nm was recorded.
Immunoprecipitation. HL60 cells were exposed to cysteine-free medium containing 80 uCi (1 Ci = 37 GBq) of [35S]cysteine (New England Nuclear) per ml for 24 hr. Fiftyto 150-,ul aliquots of medium containing labeled cysteine in a total volume of 300 1.I (buffer = 0.04 M sodium phosphate, pH 8.0/0.15 M NaCl/0. 1% Triton X-100/1 mM phenylmethylsulfonyl fluoride) were incubated with 5 pul of fibroblast CI antibody overnight at 40C. Immunoglobulin was precipitated with IgGsorb (The Enzyme Center). The precipitates were washed extensively, boiled in sample buffer (65 mM Tris HCl, pH 6.8/8 M urea/3% sodium dodecyl sulfate) and subjected to polyacrylamide gel electrophoresis. Radioautography was performed using Kodak XR-5 X-Omat R film developed at -70'C (29) .
Collagenase and CI Assays. Collagenase was assayed immunologically by an ELISA (30) and catalytically using reconstituted [14C]glycine-labeled guinea pig type I collagen fibrils [25,000 cpm/mg (31) ]. The solubilized products were quantitated in a scintillation counter. Enzyme activity was also screened using monomeric human type I and III collagen as substrate (5) .
To determine CI activity, concentrated conditioned medium was treated with EDTA (20 mM) to destroy any intrinsic enzyme, exhaustively dialyzed, and then assayed for capacity to inhibit pure fibroblast collagenase (9 (Fig. 1) . In all cases, by 2 days after induction more than 90%o of the CI was secreted into the culture medium and cellular extracts contained less than 10% of the total immunologically detectable protein (data not shown).
The kinetics of CI production following exposure of HL60 cells to the various differentiating agents is shown in Fig. 2A (for monocytic differentiation) and Fig. 2B (for granulocytic (19) . differentiation). Both the time course of (Fig. 2) and dose-response to (Fig. 1 ) the inducing substance suggest that CI synthesis correlates with differentiation/maturation ofthe Fig. 2A Inset) . Similarly, those agents that promoted monocytic differentiation [i.e., PMA and 1,25(OH)2D3] induced maximum secretion of CI within the first 24-48 hr of treatment ( Fig. 2A) . In contrast, "granulocyte-maturing" compounds (i.e., Me2SO and retinoic acid) exerted their maximum effects after the second day (Fig. 2B) . These data correspond to the acquisition by HL60 cells of monocytic or granulocytic markers when subjected to the various differentiating agents (20) (21) (22) (23) (24) (25) (26) (27) (28) . The appearance of the huiran monocytic surface marker, 63D3, on the HL60 cells could be utilized to monitor the extent of monocytic differentiation induced by agents such as 1,25(OH)2D3 (22) . In Fig. 3 , the capacity of different vitamin D3 metabolites to induce the expression of 63D3 on cell surfaces and the secretion of CI into culture medium are compared. Both 1,25(OH)2D3 and 1,25,26-trihydroxyvitamin D3 promoted monocytic differentiation (appearance of 63D3) and CI expression in a parallel fashion when HL60 cells were exposed to concentrations of these agents ranging from 0.1 nM to 0.1 ,uM (data not shown). The vitamin D metabolite 25-hydroxyvitamin D3 was capable of inducing 63D3 expression and CI release only when present in high concentration.
Other metabolites such as 24,25-and 25,26-dihydroxyvitamin D3 totally failed to promote monocyte differentiation or CI secretion (Fig. 3) . Similar conclusions were obtained when other markers of monocytic differentiation (adherence to plastic, morphology, and nonspecific esterase) were assessed (data not shown). Thus, in all instances, the extent of CI production appeared to vary precisely with the degree of cellular differentiation.
Since HL60 cells induced to differentiate along either a monocytic or a granulocytic lineage elaborated a protein detectable by antibody to human skin fibroblast CI (Figs.  1-3 ), studies were undertaken to assess the extent of structjiral similarity between the HL60 and fibroblast-derived antigens. HL60 cells exposed to PMA, 1,25(0H)2D3, Me2SO,  or retinoic acid were grown in the presence of [35S]cysteine (see Materials and Methods). Exposure of the radiolabeled medium-proteins to specific antibody directed against fibroblast CI (18, 19) resulted in the precipitation of a major band of electrophoretic mobility (Mr -28,000) identical to that of the fibroblast protein. This band was observed only with CI-specific antibody and in cells exposed to each of the differentiating agents but not in untreated cells (Fig. 4) . To further assess the nature of this immunoreactive material, 0. liters of conditioned medium from PMA-exposed cells was processed through two of the chromatographic steps used to purify human skin fibroblast CI (18) . Ninety percent of the immunoreactive material was bound to phosphocellulose at pH 7.5 as compared to only 10% of the total applied protein.
The protein eluted from the phosphocellulose column was then subjected to gel filtration using a TSK-250 HPLC column. Both the immunoreactive material and functional anti-collagenolytic activity migrated in a position identical to human skin fibroblast CI (Fig. 5) . Furthermore, protein from this inhibitor peak gave a reaction of complete identity with pure fibroblast CI when tested by double immunodiffusion (data not shown).
The functional collagenase inhibitory activity present in conditioned medium from HL60 cells exposed to the various inducing agents was next examined. As shown in Fig. 6 , such inhibitory activity invariably exhibited an approximately 1:1 molar stoichiometry with respect to exogenously added collagenase.
The ability of the HL60 cells to synthesize and secrete collagenase following their exposure to various inducing agents was also examined. Conditioned medium thus ob-O % 63D3+ P0 g Cl/106 cells Chromatographic behavior of HL60 cell-derived CI. Conditioned medium from PMA-treated HL60 cells was applied to a phosphocellulose column and eluted as described in Materials and Methods. An aliquot of the eluted material was then subjected to high pressure liquid chromatography using a Bio-Rad TSK-250 gel filtration column. The arrow denotes the elution position of pure human fibroblast CI. A229; *, immunoreactive inhibitor; o, % inhibition of collagenase activity. tained failed to exhibit either enzymatic ac monomeric or fibnllar type I and III collagens material cross-reactive with anti-human cl ELISA (30) . Treatment of the differentiated c polysaccharide or latex particles did not alter vations.
DISCUSSION
These studies show that differentiation of HL either a monocytic or granulocytic pathway is by production and secretion of a CI. This pro nologically and functionally identical to the CI normal human skin fibroblasts and by human rophages.
The expression of a CI in HL60 cells ap directly related to the extent of differentiat exposure of the cells to various inducing agents by dose-response ( Fig. 1 ) and time-course (F Furthermore, the ability of vitamin D3 metab mote CI expression was directly correlated to I to induce the appearance of the human monc 63D3 on cell surfaces and thus to their potenc tiating factors (Fig. 3) 
